GLT-1 down-regulation induced by clozapine in rat frontal cortex is associated with synaptophysin up-regulation

Luca Bragina, Marcello Melone, Giorgia Fattorini, Monica Torres-Ramos, Ainara Vallejo-Illarramendi, Carlos Matute, Fiorenzo Conti

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

In rat frontal cortex, extracellular levels of glutamate are raised by the anti-psychotic drug clozapine. We have recently shown that a significant reduction in the levels of the glutamate transporter GLT-1 may be one of the mechanisms responsible for this elevation. Here we studied whether GLT-1 down-regulation induced by chronic clozapine treatment is associated with changes in the expression of synaptophysin, synaptosome-associated protein of 25 kDa (SNAP-25) and vesicular glutamate transporter 1 (VGLUT1), three major presynaptic proteins involved in neurotransmitter release. Quantitative high-resolution confocal microscopy studies in vivo showed that GLT-1 down-regulation is closely associated with a significant increase in synaptophysin, but not SNAP-25 and VGLUT1, expression. This was confirmed in vitro studies, and in western blotting studies of synaptophysin, SNAP-25 and VGLUT1. In addition, our results show that, following clozapine treatment, synaptophysin expression increases in the very cortical regions in which GLT-1 expression is down-regulated. These findings suggest that part of the effects of clozapine may be exerted via an action on the presynaptic machinery involved in neurotransmitter release.

Original languageEnglish
Pages (from-to)134-141
Number of pages8
JournalJournal of Neurochemistry
Volume99
Issue number1
DOIs
Publication statusPublished - Oct 2006

Fingerprint

Vesicular Glutamate Transport Protein 1
Synaptophysin
Clozapine
Frontal Lobe
Synaptosomes
Rats
Up-Regulation
Down-Regulation
Neurotransmitter Agents
Proteins
Amino Acid Transport System X-AG
Confocal microscopy
Confocal Microscopy
Machinery
Glutamic Acid
Western Blotting
Pharmaceutical Preparations

Keywords

  • Antipsychotics
  • Exocytosis
  • Glutamate
  • Glutamate transport
  • Schizophrenia

ASJC Scopus subject areas

  • Biochemistry
  • Cellular and Molecular Neuroscience

Cite this

GLT-1 down-regulation induced by clozapine in rat frontal cortex is associated with synaptophysin up-regulation. / Bragina, Luca; Melone, Marcello; Fattorini, Giorgia; Torres-Ramos, Monica; Vallejo-Illarramendi, Ainara; Matute, Carlos; Conti, Fiorenzo.

In: Journal of Neurochemistry, Vol. 99, No. 1, 10.2006, p. 134-141.

Research output: Contribution to journalArticle

@article{970217d224e1425db22d6b1397f5ab9c,
title = "GLT-1 down-regulation induced by clozapine in rat frontal cortex is associated with synaptophysin up-regulation",
abstract = "In rat frontal cortex, extracellular levels of glutamate are raised by the anti-psychotic drug clozapine. We have recently shown that a significant reduction in the levels of the glutamate transporter GLT-1 may be one of the mechanisms responsible for this elevation. Here we studied whether GLT-1 down-regulation induced by chronic clozapine treatment is associated with changes in the expression of synaptophysin, synaptosome-associated protein of 25 kDa (SNAP-25) and vesicular glutamate transporter 1 (VGLUT1), three major presynaptic proteins involved in neurotransmitter release. Quantitative high-resolution confocal microscopy studies in vivo showed that GLT-1 down-regulation is closely associated with a significant increase in synaptophysin, but not SNAP-25 and VGLUT1, expression. This was confirmed in vitro studies, and in western blotting studies of synaptophysin, SNAP-25 and VGLUT1. In addition, our results show that, following clozapine treatment, synaptophysin expression increases in the very cortical regions in which GLT-1 expression is down-regulated. These findings suggest that part of the effects of clozapine may be exerted via an action on the presynaptic machinery involved in neurotransmitter release.",
keywords = "Antipsychotics, Exocytosis, Glutamate, Glutamate transport, Schizophrenia",
author = "Luca Bragina and Marcello Melone and Giorgia Fattorini and Monica Torres-Ramos and Ainara Vallejo-Illarramendi and Carlos Matute and Fiorenzo Conti",
year = "2006",
month = "10",
doi = "10.1111/j.1471-4159.2006.04030.x",
language = "English",
volume = "99",
pages = "134--141",
journal = "Journal of Neurochemistry",
issn = "0022-3042",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - GLT-1 down-regulation induced by clozapine in rat frontal cortex is associated with synaptophysin up-regulation

AU - Bragina, Luca

AU - Melone, Marcello

AU - Fattorini, Giorgia

AU - Torres-Ramos, Monica

AU - Vallejo-Illarramendi, Ainara

AU - Matute, Carlos

AU - Conti, Fiorenzo

PY - 2006/10

Y1 - 2006/10

N2 - In rat frontal cortex, extracellular levels of glutamate are raised by the anti-psychotic drug clozapine. We have recently shown that a significant reduction in the levels of the glutamate transporter GLT-1 may be one of the mechanisms responsible for this elevation. Here we studied whether GLT-1 down-regulation induced by chronic clozapine treatment is associated with changes in the expression of synaptophysin, synaptosome-associated protein of 25 kDa (SNAP-25) and vesicular glutamate transporter 1 (VGLUT1), three major presynaptic proteins involved in neurotransmitter release. Quantitative high-resolution confocal microscopy studies in vivo showed that GLT-1 down-regulation is closely associated with a significant increase in synaptophysin, but not SNAP-25 and VGLUT1, expression. This was confirmed in vitro studies, and in western blotting studies of synaptophysin, SNAP-25 and VGLUT1. In addition, our results show that, following clozapine treatment, synaptophysin expression increases in the very cortical regions in which GLT-1 expression is down-regulated. These findings suggest that part of the effects of clozapine may be exerted via an action on the presynaptic machinery involved in neurotransmitter release.

AB - In rat frontal cortex, extracellular levels of glutamate are raised by the anti-psychotic drug clozapine. We have recently shown that a significant reduction in the levels of the glutamate transporter GLT-1 may be one of the mechanisms responsible for this elevation. Here we studied whether GLT-1 down-regulation induced by chronic clozapine treatment is associated with changes in the expression of synaptophysin, synaptosome-associated protein of 25 kDa (SNAP-25) and vesicular glutamate transporter 1 (VGLUT1), three major presynaptic proteins involved in neurotransmitter release. Quantitative high-resolution confocal microscopy studies in vivo showed that GLT-1 down-regulation is closely associated with a significant increase in synaptophysin, but not SNAP-25 and VGLUT1, expression. This was confirmed in vitro studies, and in western blotting studies of synaptophysin, SNAP-25 and VGLUT1. In addition, our results show that, following clozapine treatment, synaptophysin expression increases in the very cortical regions in which GLT-1 expression is down-regulated. These findings suggest that part of the effects of clozapine may be exerted via an action on the presynaptic machinery involved in neurotransmitter release.

KW - Antipsychotics

KW - Exocytosis

KW - Glutamate

KW - Glutamate transport

KW - Schizophrenia

UR - http://www.scopus.com/inward/record.url?scp=33748684785&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748684785&partnerID=8YFLogxK

U2 - 10.1111/j.1471-4159.2006.04030.x

DO - 10.1111/j.1471-4159.2006.04030.x

M3 - Article

C2 - 16987241

AN - SCOPUS:33748684785

VL - 99

SP - 134

EP - 141

JO - Journal of Neurochemistry

JF - Journal of Neurochemistry

SN - 0022-3042

IS - 1

ER -